Nanochon Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $30M

  • Investors
  • 22

Nanochon General Information

Description

Developer of a three-dimensional printed cartilage implant designed to replace damaged cartilage and promote new tissue growth. The company's devices replace lost or damaged cartilage and encourage new tissue growth, enabling medical practitioners to access cost-effective, on-demand devices that improve outcomes for young, active patients with knee damage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7144 13th Place Northwest
  • Suite 2200
  • Washington, DC 20012
  • United States
+1 (703)
Primary Industry
Therapeutic Devices
Other Industries
Other Commercial Products
Vertical(s)
Corporate Office
  • 7144 13th Place Northwest
  • Suite 2200
  • Washington, DC 20012
  • United States
+1 (703)

Nanochon Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanochon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Later Stage VC (Series A) $30M Upcoming Clinical Trials - Phase 1
18. Secondary Transaction - Private 01-Jul-2026 Completed Clinical Trials - Phase 1
17. Later Stage VC 12-May-2026 Completed Clinical Trials - Phase 1
16. Seed Round 24-Dec-2025 Completed Clinical Trials - Phase 1
15. Accelerator/Incubator 29-May-2024 Completed Clinical Trials - Phase 1
14. Seed Round 06-May-2024 Completed Clinical Trials - Phase 1
13. Accelerator/Incubator 16-Apr-2024 Completed Clinical Trials - Phase 1
12. Grant 01-Nov-2023 Completed Clinical Trials - Phase 1
11. Seed Round 20-Sep-2023 $1.8M $3.81M Completed Clinical Trials - Phase 1
10. Grant 01-Nov-2022 $50K $2.01M Completed Clinical Trials - General
To view Nanochon’s complete valuation and funding history, request access »

Nanochon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Prime-2
Seed Prime
Seed Preferred 10,841,852 $0.000100 $0.01 $0.25 $0.25 1x $0.25 17.96%
To view Nanochon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanochon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a three-dimensional printed cartilage implant designed to replace damaged cartilage and promote new tissue
Therapeutic Devices
Washington, DC
5 As of 2026

Kfar Saba, Israel
 

Naples, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanochon Competitors (5)

One of Nanochon’s 5 competitors is CartiHeal, a Formerly VC-backed company based in Kfar Saba, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CartiHeal Formerly VC-backed Kfar Saba, Israel
Arthrex Private Equity-Backed Naples, FL
Zimmer Biomet Holdings Corporation Warsaw, IN
Vericel Formerly PE-Backed Burlington, MA
Anika Therapeutics Formerly VC-backed Bedford, MA
You’re viewing 5 of 5 competitors. Get the full list »

Nanochon Patents

Nanochon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026101844-A1 Tissue implant and uses thereof Pending 05-Nov-2024
WO-2025174792-A1 Non-adhesively affixed tissue scaffolds Pending 13-Feb-2024
WO-2025174829-A1 Surgical tools for implanting a tissue scaffold Pending 13-Feb-2024
EP-3829663-A1 Implantable scaffolds and uses thereof Active 30-Jul-2018
EP-3829663-A4 Implantable scaffolds and uses thereof Active 30-Jul-2018 A61L27/56
To view Nanochon’s complete patent history, request access »

Nanochon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanochon Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ecphora Capital Venture Capital Minority
TEDCO Venture Capital Minority
University of Virginia University Minority
Wilson Sonsini Goodrich & Rosati VC-Backed Company Minority
MedTech Innovator Accelerator/Incubator
You’re viewing 5 of 22 investors. Get the full list »

Nanochon FAQs

  • When was Nanochon founded?

    Nanochon was founded in 2013.

  • Where is Nanochon headquartered?

    Nanochon is headquartered in Washington, DC.

  • What is the size of Nanochon?

    Nanochon has 5 total employees.

  • What industry is Nanochon in?

    Nanochon’s primary industry is Therapeutic Devices.

  • Is Nanochon a private or public company?

    Nanochon is a Private company.

  • What is Nanochon’s current revenue?

    The current revenue for Nanochon is .

  • How much funding has Nanochon raised over time?

    Nanochon has raised $12.2M.

  • Who are Nanochon’s investors?

    Ecphora Capital, TEDCO, University of Virginia, Wilson Sonsini Goodrich & Rosati, and MedTech Innovator are 5 of 22 investors who have invested in Nanochon.

  • Who are Nanochon’s competitors?

    CartiHeal, Arthrex, Zimmer Biomet Holdings, Vericel, and Anika Therapeutics are competitors of Nanochon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process